File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.12968/bjca.2015.10.5.223
- Find via
Supplementary
-
Citations:
- Appears in Collections:
Article: No-reflow phenomenon during PCI in acute myocardial infarction
| Title | No-reflow phenomenon during PCI in acute myocardial infarction |
|---|---|
| Authors | |
| Issue Date | 2015 |
| Publisher | Mark Allen Healthcare. The Journal's web site is located at http://www.magonlinelibrary.com/toc/bjca/current |
| Citation | British Journal of Cardiac Nursing, 2015, v. 10 n. 5, p. 223-228 How to Cite? |
| Abstract | No-reflow phenomenon complicates percutaneous coronary intervention in acute myocardial infarction. It significantly affects cardiac prognosis and clinical outcome. The underlying causes of no-reflow are ischaemia/reperfusion-related injury, coronary microcirculation injury and distal embolisation. Thrombolysis in myocardial infarction, myocardial blush grade and myocardial contrast echocardiography are commonly used to diagnose no-reflow phenomenon. Several pharmacological agents and mechanical devices effectively prevent and treat no-reflow. This article presents a patient with acute myocardial infarction who experienced no-reflow phenomenon during percutaneous coronary intervention. He is successfully treated with intracoronary nitroprusside, nitroglycerin (TNG), intra-arterial verapamil and intravenous abciximab. |
| Persistent Identifier | http://hdl.handle.net/10722/239602 |
| ISSN |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lam, AHY | - |
| dc.date.accessioned | 2017-03-21T09:16:23Z | - |
| dc.date.available | 2017-03-21T09:16:23Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | British Journal of Cardiac Nursing, 2015, v. 10 n. 5, p. 223-228 | - |
| dc.identifier.issn | 1749-6403 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/239602 | - |
| dc.description.abstract | No-reflow phenomenon complicates percutaneous coronary intervention in acute myocardial infarction. It significantly affects cardiac prognosis and clinical outcome. The underlying causes of no-reflow are ischaemia/reperfusion-related injury, coronary microcirculation injury and distal embolisation. Thrombolysis in myocardial infarction, myocardial blush grade and myocardial contrast echocardiography are commonly used to diagnose no-reflow phenomenon. Several pharmacological agents and mechanical devices effectively prevent and treat no-reflow. This article presents a patient with acute myocardial infarction who experienced no-reflow phenomenon during percutaneous coronary intervention. He is successfully treated with intracoronary nitroprusside, nitroglycerin (TNG), intra-arterial verapamil and intravenous abciximab. | - |
| dc.language | eng | - |
| dc.publisher | Mark Allen Healthcare. The Journal's web site is located at http://www.magonlinelibrary.com/toc/bjca/current | - |
| dc.relation.ispartof | British Journal of Cardiac Nursing | - |
| dc.title | No-reflow phenomenon during PCI in acute myocardial infarction | - |
| dc.type | Article | - |
| dc.identifier.email | Lam, AHY: angielam@hku.hk | - |
| dc.identifier.doi | 10.12968/bjca.2015.10.5.223 | - |
| dc.identifier.hkuros | 271397 | - |
| dc.identifier.volume | 10 | - |
| dc.identifier.issue | 5 | - |
| dc.identifier.spage | 223 | - |
| dc.identifier.epage | 228 | - |
| dc.publisher.place | United Kingdom | - |
| dc.identifier.issnl | 1749-6403 | - |